Pediatric poisoning from trimedoxime (TMB4) and atropine automatic injectors.

Autor: Kozer E; Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. erank@asaf.health.gov.il, Mordel A, Haim SB, Bulkowstein M, Berkovitch M, Bentur Y
Jazyk: angličtina
Zdroj: The Journal of pediatrics [J Pediatr] 2005 Jan; Vol. 146 (1), pp. 41-4.
DOI: 10.1016/j.jpeds.2004.08.056
Abstrakt: Objective: To describe the effects of combined trimedoxime (TMB4) and atropine poisoning from automatic injectors (AI) in children.
Study Design: Data was collected from two sources: calls to the Israel Poison Information Center (IPIC) during a 1-year period and a cohort of children who presented to pediatric emergency departments (EDs) after unintentional injection of an AI. Demographic data and data regarding the type of AI, site and time of injection, and the clinical manifestations were abstracted.
Results: Data were available for 142 patients. The median age was 8.5 years (range 1.25-18 years). The dose of atropine and TMB4 was higher than the recommended dose for age in 22 (15.5%) cases. There were few side effects attributable to atropine: dilated pupils (26.7%), dryness of mucous membranes (24.6%), and tachycardia (22.5%). Compared with children injected with an age-appropriate dose, children injected with an AI that contained a dose that exceeds the recommended one were more likely to be symptomatic ( P = .029). There were no side effects characteristic to oximes, and no specific medical intervention was required.
Conclusions: Unintentional pediatric atropine and TMB4 injection, even an adult dose in a small child, does not cause significant side effects.
Databáze: MEDLINE
Externí odkaz: